FT Options’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-83,600
Closed -$7K 246
2017
Q2
$7K Buy
83,600
+68,400
+450% +$444K 0.01% 168
2017
Q1
$16K Sell
15,200
-12,800
-46% -$61.5K 0.02% 207
2016
Q4
$297K Sell
28,000
-77,400
-73% -$567K 0.34% 60
2016
Q3
$320K Buy
+105,400
New +$1.51M 0.25% 80

Other funds holding DVAX

FT Options's DVAX Position: Q3 2017 in Review

FT Options sold out of Dynavax Technologies (DVAX) in Q3 2017, closing a stake of 30,795 shares — an estimated $487K sold.

FT Options first reported a position in DVAX in Q4 2015 and held it in 4 quarters. The position peaked at $1.14M in Q4 2015. 119 funds tracked by Wall St. Rank hold DVAX as of Q3 2017.

  • FT Options reported no remaining Dynavax Technologies position as of Q3 2017 after selling out during the quarter.
  • FT Options sold 30,795 Dynavax Technologies shares in Q3 2017, an estimated $487K.
  • FT Options first reported a position in Dynavax Technologies in Q4 2015 and held it in 4 quarters.
  • FT Options's Dynavax Technologies position peaked at $1.14M in Q4 2015.
  • 119 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.